The Kingston Report

The Kingston Report

Share this post

The Kingston Report
The Kingston Report
MRNA is on a Major Losing Streak

MRNA is on a Major Losing Streak

Moderna (MRNA) has dropped more than 17% in value per the stock’s current 5-day losing streak, and more than 50% in value year-to-date.

Karen Kingston's avatar
Karen Kingston
Oct 18, 2023
∙ Paid
140

Share this post

The Kingston Report
The Kingston Report
MRNA is on a Major Losing Streak
20
12
Share

October 17, 2023: Moderna stock (MRNA) drastically dropped -6.1% (-$5.61 per share) today rounding out a -17.63% (-$18.61 per share) 5-day losing streak for MRNA.

Despite Moderna’s Monday news release basically alluding that, “Everything is fine. Nothing to see here. Sales are solid. Pfizer’s a loser, but not MRNA,” investors didn’t buy the companies ‘mi…

Keep reading with a 7-day free trial

Subscribe to The Kingston Report to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Karen Kingston
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share